{
    "clinical_study": {
        "@rank": "35085", 
        "arm_group": [
            {
                "arm_group_label": "Group L (number of participants=30)", 
                "arm_group_type": "Active Comparator", 
                "description": "After standard anesthesia induction and before surgery, patients will receive submucosal infiltration of 12 mL lidocaine 2%, 1mg/kg into nasal cavity."
            }, 
            {
                "arm_group_label": "Group K (number of participants=30)", 
                "arm_group_type": "Active Comparator", 
                "description": "After standard anesthesia induction and before surgery, patients will receive submucosal infiltration of 12 mL ketamine 0.5 mg/kg  plus lidocaine 2% 1 mg/kg  of the intranasal cavity."
            }, 
            {
                "arm_group_label": "Group S  (number of participants=30)", 
                "arm_group_type": "Placebo Comparator", 
                "description": "After standard anesthesia induction and before surgery, patients will receive submucosal infiltration of saline 12 mL into intranasal cavity."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether subanesthetic ketamine addition to\n      lidocaine decreases postoperative pain scores in infiltration anesthesia during rhinoplasty."
        }, 
        "brief_title": "Effect of Ketamine Addition to Lidocaine in Rhinoplasty", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": "Nose Deformities, Acquired", 
        "condition_browse": {
            "mesh_term": [
                "Congenital Abnormalities", 
                "Nose Deformities, Acquired"
            ]
        }, 
        "detailed_description": {
            "textblock": "In rhinoplasty operations local infiltration anesthesia uses for surgery insight and patient\n      comfort. The investigators designed this study to prolonged the time of infiltration block\n      and preventive analgesia. So, before operation, study drugs will infiltrate to the submucosa\n      of intranasal cavity. Then, surgeon and patient satisfaction, postoperative analgesic\n      demand, postoperative pain scores and side effects will determine."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients scheduled for elective rhinoplasty operation under general anesthesia\n\n          -  Patients with ASA (American Society of Anesthesiology) class I\n\n          -  Patients between 18-50 years old\n\n        Exclusion Criteria:\n\n          -  Age <18 and >50\n\n          -  ASA > II\n\n          -  Preexisting neurological or psychiatric illness\n\n          -  Systemic diseases (diabetes mellitus, hypertension, coronary heart disease...)\n\n          -  Having a history of chronic pain and receiving chronic analgesia therapy\n\n          -  Having a history of drug abuse"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01827020", 
            "org_study_id": "Mukadder"
        }, 
        "intervention": [
            {
                "arm_group_label": "Group L (number of participants=30)", 
                "description": "12 mL lidocaine 2% 1mg/kg", 
                "intervention_name": "Lidocaine 2 %", 
                "intervention_type": "Drug", 
                "other_name": "preincisional infiltration of lidocaine"
            }, 
            {
                "arm_group_label": "Group K (number of participants=30)", 
                "description": "ketamine 0.5 mg/kg + Lidocaine 2% 1 mg/kg in total volume of 12 mL", 
                "intervention_name": "Ketamine plus Lidocaine", 
                "intervention_type": "Drug", 
                "other_name": "preincisional infiltration of ketamine plus lidocaine"
            }, 
            {
                "arm_group_label": "Group S  (number of participants=30)", 
                "description": "12 mL saline (0.9% isotonic solution)", 
                "intervention_name": "Saline", 
                "intervention_type": "Drug", 
                "other_name": "preincisional infiltration of saline"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ketamine", 
                "Lidocaine"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "April 8, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Malatya", 
                    "country": "Turkey", 
                    "zip": "44315"
                }, 
                "name": "Turgut Ozal Medical Center"
            }
        }, 
        "location_countries": {
            "country": "Turkey"
        }, 
        "number_of_arms": "3", 
        "official_title": "Effect of Ketamine Addition to Lidocaine for Postoperative Pain Management in Rhinoplasty", 
        "other_outcome": {
            "description": "Sedation, nausea and vomiting, dizziness, and hallucination will examine as an adverse effect in all patients.", 
            "measure": "Number of participants with adverse effects as a measure of safety and tolerability", 
            "safety_issue": "Yes", 
            "time_frame": "24 hour"
        }, 
        "overall_official": {
            "affiliation": "Turgut Ozal Medical Center", 
            "last_name": "Mukadder Sanli, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Pain scores will examine with Visual analogue scale (VAS, 0-100) in the first 24 hours of postoperative period. The examination will repeated in different time period(5.min, 15.min, 30.min, 1 h, 2h,4.h, 6.h, 8.h, 16.h, 24.h). Patients that have VAS>40 will receive 1mg/kg tramadol.", 
            "measure": "Postoperative pain scores on the Visual Analogue Scale", 
            "safety_issue": "Yes", 
            "time_frame": "24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01827020"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Inonu University", 
            "investigator_full_name": "Mukadder Sanli", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": {
            "PMID": "22328829", 
            "citation": "Honarmand A, Safavi M, Karaky H. Preincisional administration of intravenous or subcutaneous infiltration of low-dose ketamine suppresses postoperative pain after appendectomy. J Pain Res. 2012;5:1-6. doi: 10.2147/JPR.S26476. Epub 2011 Dec 30."
        }, 
        "secondary_outcome": [
            {
                "description": "At the end of postoperative 24 h, the patient satisfaction will examine by a score as (1 poor, 2 middle, 3 good, 4 perfect)", 
                "measure": "Patient satisfaction", 
                "safety_issue": "Yes", 
                "time_frame": "24 hour"
            }, 
            {
                "description": "At the first day of postoperative period, analgesic requirement will record. When Visual analogue scale > 40, intravenous 1 mg/kg tramadol bolus will give.", 
                "measure": "Analgesic demand", 
                "safety_issue": "Yes", 
                "time_frame": "24 hour"
            }
        ], 
        "source": "Inonu University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Inonu University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}